SCHEMBL1815053

SCHEMBL1815053

COc1cc2c(O)cc3c(c2cc1OC)-c1ccc(-c2ccccc2C(F)(F)F)cc1C3(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 3/20 0.42
AR P10275 2/20 0.38
PGR P06401 1/20 0.38
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
TRPA1 O75762 2/20 0.35
CTSA P10619 1/20 0.35
CYP2D6 P10635 3/20 0.35
TSHR P16473 3/20 0.35
MAPK1 P28482 3/20 0.35
CYP2C19 P33261 3/20 0.35
USP2 O75604 2/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
HIF1A Q16665 1/20 0.35
MCHR1 Q99705 1/20 0.35
ALDH1A1 P00352 3/20 0.34
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1814761 0.88 ALDH1A1 (0.36) PDK2ARPGRCYP2D6TSHR
SCHEMBL164415 0.87 PDK2 (0.40) PDK2ARPGRALOX5APFEN1
SCHEMBL30125488 0.87 PDK2 (0.47) PDK2ARPGRALOX5APFEN1
SCHEMBL8513816 0.87 PDK2 (0.47) PDK2ARPGRALOX5APFEN1
SCHEMBL1816187 0.85 PDK2 (0.39) PDK2ARPGRALOX5APFEN1
SCHEMBL1816876 0.84 IDO1 (0.39) PDK2ALOX5APFEN1CYP2D6CYP2C19
SCHEMBL1010811 0.83 EGFR (0.38) PDK2MEN1KMT2APDE4A
SCHEMBL164197 0.83 EGFR (0.38) PDK2MEN1KMT2APDE4A
SCHEMBL1815597 0.82 KCNH2 (0.36) PDK2ARPGRALOX5APFEN1
SCHEMBL165110 0.81 PDK2 (0.40) PDK2ARPGRTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2494408-B9 PHOTOCHROMIC MATERIALS TRANSITIONS OPTICAL INC (US) 2015-09-02 EP disclosed
EP-2494408-B1 PHOTOCHROMIC MATERIALS TRANSITIONS OPTICAL INC (US) 2015-04-15 EP disclosed
US-8647538-B2 Photochromic compounds having at least two photochromic moieties TRANSITIONS OPTICAL, INC. (US) 2014-02-11 US disclosed
US-8518305-B2 Photochromic materials TRANSITIONS OPTICAL, INC. (US) 2013-08-27 US disclosed
US-20120136148-A1 Photochromic Compounds Having At Least Two Photochromic Moieties TRANSITIONS OPTICAL, INC. (US) 2012-05-31 US disclosed
US-20110108781-A1 PHOTOCHROMIC MATERIALS TRANSITIONS OPTICAL, INC. (US) 2011-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110108781-A1 PHOTOCHROMIC MATERIALS INCENP, SMCHD1, NEDD8 PDK2 2668/4885AR 2701/4885PGR 2143/4885
US-20120136148-A1 Photochromic Compounds Having At Least Two Photochromic Moieties CRY2, PCNA, MTCL3 PDK2 3140/4885AR 4580/4885PGR 4237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.